NewsIn memory
Brad Arnold's Kidney Cancer: Understanding Stage 4 RCC
3 Doors Down singer Brad Arnold disclosed metastatic clear-cell kidney cancer before his death. Learn about symptoms, diagnosis, risk, and modern treatment.
Original commentary from the Cancer Explained editorial team.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What he said, and when
In May 2025, Brad Arnold, the singer of 3 Doors Down, said he had stage four cancer. The Guardian reported his account: he had felt unwell for several weeks, went to hospital for tests, and was told he had a renal carcinoma that had spread to his lung.
The Associated Press reported that he died on Saturday, February 7, 2026, at 47, months after that announcement. The band's statement said he died peacefully, surrounded by loved ones.
The Associated Press reported that the diagnosis he announced was clear cell renal carcinoma that had metastasised to his lungs. Beyond that, his own account is the whole public record of his illness. What his words do give is a chance to unpack a phrase most people have never had explained.
Renal carcinoma, in plain terms
The kidneys are two bean-shaped organs at the back of the abdomen, roughly level with the lowest ribs. They filter blood and make urine.
Renal cell cancer starts in the tiny tubes that do that filtering. NCI reports that about 85 percent of renal cell cancers are adenocarcinomas, most arising from the proximal tubule. Most of the rest are transitional cell carcinomas of the renal pelvis, which is the funnel where urine collects before draining away.
Adenocarcinomas are further split by how the cells look under a microscope, into clear cell and granular cell types. Clear cell is the common one. Some tumors contain both.
The subtype is not a detail. It decides which drugs are likely to work. Our page on kidney cancer types explains how a pathology report sets that out.
What stage 4 means, and what it does not
Stage describes reach. Stage 4 renal cell cancer has grown beyond the kidney and its immediate surroundings, or has traveled to a distant organ.
Here is the part people get wrong. When kidney cancer cells settle in the lung, that is still kidney cancer. It is not lung cancer. The cells kept their original identity, and they are treated as kidney cancer cells. Our explainer on kidney cancer stages lays out the full scale.
NCI states that when distant metastases are present, disease-free survival is poor. It also notes something unusual about this cancer: some people with locally advanced or metastatic disease follow slow courses lasting several years, late recurrences many years afterward do happen, and renal cell cancer is one of the few tumors with well-documented cases of spontaneous regression without any treatment, though NCI adds that this happens rarely and may not lead to long-term survival.
How advanced kidney cancer is treated now
The list of first-line options NCI publishes looks nothing like it did fifteen years ago. Chemotherapy is barely on it.
Two families of drug dominate. Immune checkpoint inhibitors release a brake the tumor uses to hide from immune cells — ipilimumab plus nivolumab is one such pairing. Antiangiogenic targeted drugs choke off the blood supply the tumor builds for itself. Modern first-line therapy usually combines the two, for example pembrolizumab with axitinib, pembrolizumab with lenvatinib, or nivolumab with cabozantinib.
Surgery still has a role. Cytoreductive nephrectomy removes the primary kidney tumor even when the cancer has already spread, in selected people. Radiation is used to relieve symptoms rather than to cure. Later lines include belzutifan, which blocks a protein called HIF-2alpha that clear cell tumors rely on.
Which of these fits depends on pathology, where and how fast the disease is moving, other health conditions, prior treatment, and what a person wants.
Signs worth acting on
Kidney cancer is often found by accident, on a scan ordered for something else. When it does announce itself, these are the usual ways.
- Visible blood in the urine, even once, even if it clears. This always needs a same-week appointment.
- A dull, persistent ache in the side or the back below the ribs that does not shift with position.
- A lump you can feel in the side or abdomen.
- Weight loss you did not plan for, poor appetite, or a fever with no infection to explain it.
- Tiredness with anemia found on a blood test, meaning too few red cells.
Most of these turn out to be something else. Blood in the urine in particular is far more often a stone or an infection. It still gets looked at.
There is no routine kidney cancer screening for people at average risk. Smoking, obesity, high blood pressure, some inherited syndromes, and certain workplace exposures are linked to higher risk. Not smoking and treating high blood pressure are worth doing on their own merits. Neither prevents every case.
What this story cannot tell you
- Clear cell is the subtype named in the Associated Press report, and nothing further about his pathology is public. Any account that adds detail has gone beyond the record.
- His course does not predict anyone else's. Response to checkpoint immunotherapy varies enormously between people with the same stage.
- A lung finding in someone with kidney cancer is not a second, separate cancer.
- "Stage 4" is a description of spread. It is not a timeline and not a single treatment plan.
- SEER's overall five-year relative survival for kidney and renal pelvis cancer, covering diagnoses from 2016 through 2022, is 79.2 percent, but that figure is carried by the 66 percent of cases found while still confined to the kidney. For distant disease in that same period, SEER records 20.3 percent. These are group averages from people diagnosed years ago. They describe populations, not any individual.
Sources
- Associated Press: 3 Doors Down lead singer Brad Arnold dies at 47
- The Guardian: Brad Arnold diagnosed with stage four cancer, May 2025
- NCI PDQ: Renal Cell Cancer Treatment (Health Professional Version)
- NCI SEER Cancer Stat Facts: Kidney and Renal Pelvis Cancer
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Metastatic kidney cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.